Ҵý

Focus: Stem Cells

Filters close
Go to Advanced Search
Ҵý: Gene Therapy Restores Immune Function and Extends Lives of Children with Rare Immune Disorder
Released: 30-Apr-2025 5:00 PM EDT
Gene Therapy Restores Immune Function and Extends Lives of Children with Rare Immune Disorder
University of California, Los Angeles (UCLA), Health Sciences

Two years after receiving an investigational gene therapy as part of a clinical trial co-led by UCLA’s Dr. Donald Kohn, nine children born with a life-threatening immune disorder are living free of disease symptoms.

Ҵý: New Cell Sorting Strategy Enhances Stem Cell Purity for Cultured Meat Production
Released: 30-Apr-2025 5:30 AM EDT
New Cell Sorting Strategy Enhances Stem Cell Purity for Cultured Meat Production
Chinese Academy of Sciences

A research team has developed a novel strategy for isolating high-purity muscle stem cells (MuSCs), fibro-adipogenic progenitors (FAPs), and smooth muscle cells (SMCs) from porcine muscle tissue.

Released: 26-Apr-2025 12:00 PM EDT
EZH2, via an Association with KDM2B, Modulates Osteogenic Differentiation of Root Apical Papillary Stem Cells
World Journal of Stem Cells

BACKGROUNDStem cells from apical papilla (SCAPs) represent promising candidates for bone regenerative therapies due to their osteogenic potential. However, enhancing their differentiation capacity remains a critical challenge. Enhancer of z

Released: 26-Apr-2025 12:00 PM EDT
L-Arginine From Elder Human Mesenchymal Stem Cells Induces Angiogenesis and Enhances Therapeutic Effects on Ischemic Heart Diseases
World Journal of Stem Cells

BACKGROUNDMesenchymal stem cell (MSC)-based therapy may be a future treatment for myocardial infarction (MI). However, few studies have assessed the therapeutic efficacy of adipose tissue-derived MSCs (ADSCs) obtained from elderly patients

Released: 26-Apr-2025 12:00 PM EDT
Rna Interference-Mediated Osteoprotegerin Silencing Increases the Receptor Activator of Nuclear Factor-Kappa B Ligand/Osteoprotegerin Ratio and Promotes Osteoclastogenesis
World Journal of Stem Cells

BACKGROUNDIn vivo degradation of bone scaffolds is significantly influenced by osteoclast (OC) activity, which is orchestrated by the interplay between receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG). T

Released: 26-Apr-2025 12:00 PM EDT
Hypoxic Endometrial Epithelial Cell-Derived microRNAs Effectively Regulate the Regenerative Properties of Mesenchymal Stromal Cells
World Journal of Stem Cells

Endometrial thickness plays an important role in successful embryo implantation and normal pregnancy achievement. However, a thin endometrial layer (≤ 7 mm) may have a significant effect on microenvironment tolerance, which is further rel

Released: 26-Apr-2025 12:00 PM EDT
Stem Cell Therapy for Intervertebral Disc Degeneration: Clinical Progress with Exosomes and Gene Vectors
World Journal of Stem Cells

Intervertebral disc degeneration is a leading cause of lower back pain and is characterized by pathological processes such as nucleus pulposus cell apoptosis, extracellular matrix imbalance, and annulus fibrosus rupture. These pathological

Released: 26-Apr-2025 12:00 PM EDT
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomal miR-199a-3p inhibits the MAPK4/NF-κB Signaling Pathway to Relieve Osteoarthritis
World Journal of Stem Cells

BACKGROUNDThere is currently no effective treatment for osteoarthritis (OA), which is the most common joint disorder leading to disability. Although human umbilical cord mesenchymal stem cells (hUC-MSCs) are promising OA treatments, their u

Released: 26-Apr-2025 12:00 PM EDT
Exosomal Mir-137-3p Targets UBE3C to Activate STAT3, Promoting Migration and Differentiation Into Endometrial Epithelial Cell of Human Umbilical Cord Mesenchymal Stem Cells Under Hypoxia
World Journal of Stem Cells

BACKGROUNDThin endometrium, leading cause of recurrent implantation failure and infertility, has been found to respond to exosomes. AIMTo investigate the efficacy of exosomes in addressing the issue of thin endometrium. METHODSRNA sequenc

Released: 26-Apr-2025 12:00 PM EDT
Mechanisms and Challenges of Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis
World Journal of Stem Cells

In this editorial, we comment on the recent article by Xiao et al, focusing on their investigation into whether the therapeutic efficacy of serum-free human umbilical cord mesenchymal stem cells (MSCs) differs from that of serum-containing

Released: 26-Apr-2025 12:00 PM EDT
Non-Coding RNAs in Adipose-Derived Stem Cell Exosomes: Mechanisms, Therapeutic Potential, and Challenges in Wound Healing
World Journal of Stem Cells

The treatment of complex wounds presents a significant clinical challenge due to the limited availability of standardized therapeutic options. Adipose-derived stem cell exosomes (ADSC-Exos) are promising for their capabilities to enhance an

Released: 26-Apr-2025 12:00 PM EDT
Enhancing the Clinical Translation of Stem Cell Models by Focusing on Standardization and International Regulatory Cooperation
World Journal of Stem Cells

The article by Granjeiro et al provided a thorough review of the role of stem cell models in the development of advanced therapy medicinal products. It emphasized the potential of stem cell models to refine preclinical studies and align wit

Released: 26-Apr-2025 12:00 PM EDT
Effectiveness of Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Parkinson’s Disease: A Systematic Review of Preclinical Studies
World Journal of Stem Cells

BACKGROUNDMesenchymal stem cell-derived extracellular vesicles (MSC-EVs) can traverse the blood-brain barrier due to their small size. This characteristic makes them a research hotspot for the treatment of Parkinson’s disease (PD) and is

Released: 26-Apr-2025 12:00 PM EDT
Evaluating the Efficacy of Stem Cells in Treating Severe Dry Eye Disease
World Journal of Stem Cells

Dry eye disease (DED) is a multifactorial disorder that disturbs ocular surface equilibrium, considerably diminishing quality of life. Present therapies only offer symptomatic alleviation. Stem cell treatment, especially mesenchymal stem ce

Ҵý: 1920_gettyimages-1372020576.jpg?10000
Released: 24-Apr-2025 8:15 PM EDT
Expert Q&A: ‘Invisible’ Stem Cells
Cedars-Sinai

Cedars-Sinai is a leading transplant center, with patient outcomes that consistently meet or exceed national averages. One continuing challenge, however, is the need to suppress transplant patients’ immune systems to prevent their bodies from rejecting the transplant.

Ҵý: 1920_biomanufacturing-center-cedars-sinai.jpg?10000
Released: 18-Apr-2025 11:00 AM EDT
Cedars-Sinai Marks 15 Years of Regenerative Medicine
Cedars-Sinai

The Cedars-Sinai Board of Governors Regenerative Medicine Institute is marking its 15th anniversary by further expanding its commitment to research, development of cell-based human models and therapies, and education with three new leadership appointments and the creation of a master’s degree program.

Ҵý: Reprogramming Cancer Cells to Treat an Aggressive Type of Leukemia
Released: 16-Apr-2025 5:15 PM EDT
Reprogramming Cancer Cells to Treat an Aggressive Type of Leukemia
Ludwig Cancer Research

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Released: 15-Apr-2025 6:40 PM EDT
Guinea Pigs: A Promising Animal Model to Study the Human Embryo
Universite de Montreal

CRCHUM researchers reveal that the guinea pig pre-implantation embryo is very similar to the human embryo, spurring a better understanding of infertility and early human development.

   
Released: 9-Apr-2025 6:30 PM EDT
Hidden Forces Shape Plants From the Inside Out
Universite de Montreal

UdeM scientists use a combination of experimental data and modelling to reveal how physical forces help plants to generate their complex 3D shapes.

Released: 8-Apr-2025 7:05 AM EDT
Ventris Medical Receives Additional FDA Clearance for Backpack® Bone Graft in the Intervertebral Disc Space
Ventris Medical

Ventris Medical, a privately held orthobiologics and tissue regeneration company, today announced that the United States Food and Drug Administration has granted 510(k) clearance for Backpack® (Porous Biologic Scaffold, K250556) for use in the Intervertebral Disc Space.

   


close
1.67807